Infliximab for Managing Steroid-Refractory Acute Graft-versus-Host Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Infliximab for Managing Steroid-Refractory Acute Graft-versus-Host Disease

Published:2009-09 Issue:9 Volume:15 Page:1116-1121
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Pidala Joseph,Kim Jongphil,Field Teresa,McBride Ali,Kharfan-Dabaja Mohamed,Perkins Janelle,Fernandez Hugo,Perez Lia,Ayala Ernesto,Anasetti Claudio

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference45 articles.

1. Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems;MacMillan;Biol Blood Marrow Transplant,2002

2. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation;Hill;Blood,2000

3. Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk factors and outcome;Weisdorf;Blood,1990

4. Cytokine dysregulation and acute graft-versus-host disease;Antin;Blood,1992

5. Hematopoietic stem cell transplantation;Copelan;N Engl J Med,2006

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study;Annals of Hematology;2023-07-20

2. Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study;Cancers;2023-07-13

3. Vedolizumab in highly resistant acute gastrointestinal graft-versus-host disease after allogeneic stem cell transplantation: A single-center pediatric series;Advances in Clinical and Experimental Medicine;2022-02-25

4. Immunosuppressive agents and monitoring in long‐term survivors;Blood and Marrow Transplantation Long Term Management;2021-03-19

5. Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label phase 2 trial;Blood;2020-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3